These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 4308762)

  • 21. [Advances and principles in tuberculostatic therapy].
    Bethge H
    Internist (Berl); 1971 Aug; 12(8):328-31. PubMed ID: 4328130
    [No Abstract]   [Full Text] [Related]  

  • 22. [Cheotherapy of chronic pulmonary tuberculosis with resistant mycobacteria].
    Fegiz G
    Policlinico Prat; 1967 Oct; 74(43):1454-62. PubMed ID: 5629122
    [No Abstract]   [Full Text] [Related]  

  • 23. CHEMOTHERAPY REGIMENS USED IN RETREATMENT OF PULMONARY TUBERCULOSIS. II. OBSERVATIONS ON THE EFFICACY OF COMBINATIONS OF ETHAMBUTOL, CAPREOMYCIN AND COMPANION DRUGS, INCLUDING 4-4 DIISOAMYLOXYTHIOSEMICARBANILIDE.
    KASS I
    Tubercle; 1965 Jun; 46():166-77. PubMed ID: 14327964
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of antitubercular agents of the 2d series: ethionamide, ethoxyd cycloserine and pyrazinamide on the development of drug resistance of Mycobacterium tuberculosis to tubazide and phthivazide].
    Makeeva OO
    Farmakol Toksikol; 1969; 32(2):202-5. PubMed ID: 4977183
    [No Abstract]   [Full Text] [Related]  

  • 25. [Preparations of the 2d series in the complex treatment of middle-aged and elderly patients with pulmonary tuberculosis].
    Iaschenko BP
    Probl Tuberk; 1967; 45(9):21-6. PubMed ID: 4303748
    [No Abstract]   [Full Text] [Related]  

  • 26. Duration of application and change of a regimen with secondary drugs.
    Oka S; Takase Y; Kato S
    Sci Rep Res Inst Tohoku Univ Med; 1968 Oct; 15(1):46-9. PubMed ID: 4308926
    [No Abstract]   [Full Text] [Related]  

  • 27. [The treatment of urogenital tuberculosis with current drugs].
    König K; May P
    Urologe; 1968; 7(1):23-9. PubMed ID: 4297580
    [No Abstract]   [Full Text] [Related]  

  • 28. Newer and second-line drugs in the treatment of drug-resistant tuberculosis in children.
    Steiner M
    Med Clin North Am; 1967 Sep; 51(5):1153-67. PubMed ID: 4297572
    [No Abstract]   [Full Text] [Related]  

  • 29. Ethambytol in the retreatment of pulmonary tuberculosis. United States Public Health Service cooperative trial.
    Steininger WJ
    Bull Int Union Tuberc; 1968 Dec; 41():181-2. PubMed ID: 4303861
    [No Abstract]   [Full Text] [Related]  

  • 30. Efficacy and safety of kanamycin, ethionamide, PAS and cycloserine in multidrug-resistant pulmonary tuberculosis patients.
    Prasad R; Verma SK; Sahai S; Kumar S; Jain A
    Indian J Chest Dis Allied Sci; 2006; 48(3):183-6. PubMed ID: 18610675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Incidence of wild strains of Mycobacterium tuberculosis in variants resistant to minor antibiotics (p-aminosalicylic acid, ethionamide, cycloserine, viomycin, kanamycin)].
    GROSSET J; CANETTI G
    Ann Inst Pasteur (Paris); 1962 Aug; 103():163-84. PubMed ID: 13902273
    [No Abstract]   [Full Text] [Related]  

  • 32. Drug therapy of resistant cases of pulmonary tuberculosis in Indian patients.
    Mital OP; Agarwala MC; Singh SK
    Indian J Chest Dis; 1967 Oct; 9(4):196-206. PubMed ID: 4323543
    [No Abstract]   [Full Text] [Related]  

  • 33. [The results of treatment with minor drugs, i.e. kanamycin, ethionamide and cycloserine, for severe pulmonary tuberculosis patients discharging bacilli resistant to all the three major drugs].
    Matsumoto M; Izumi K; Kamima H; Hirose H; Saito M
    Kekkaku; 1966 Jan; 41(1):39-46. PubMed ID: 5962711
    [No Abstract]   [Full Text] [Related]  

  • 34. Radiometric vs. agar proportion methods for assessing ethionamide resistance and its clinical effects in multidrug-resistant tuberculosis.
    Cimen NO; Arslan Z; Saygi A; Ocak K; Babacan F; Kurutepe M
    Int J Tuberc Lung Dis; 2009 Jul; 13(7):907-13. PubMed ID: 19555543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resistance of Mycobacterium tuberculosis to antituberculosis drugs in the Central Region of Thailand, 1996.
    Riantawan P; Punnotok J; Chaisuksuwan R; Pransujarit V
    Int J Tuberc Lung Dis; 1998 Aug; 2(8):616-20. PubMed ID: 9712274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative studies of various antituberculosis drug regimens by means of serum antimycobacterial activity tests in man.
    Hokama S
    Jpn J Tuberc; 1967 Jul; 14(1):55-65. PubMed ID: 5300098
    [No Abstract]   [Full Text] [Related]  

  • 37. Improvement of drg-sensitivity tests on tubercle bacilli.
    Leat JL; Marks J
    Tubercle; 1970 Mar; 51(1):68-75. PubMed ID: 4099827
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of chronic destructive forms of pulmonary tuberculosis with drugs of the second series in different combinations].
    Mamolat AS; Bialik IB
    Probl Tuberk; 1969; 47(6):23-8. PubMed ID: 4311969
    [No Abstract]   [Full Text] [Related]  

  • 39. Kanamycin in the therapy of pulmonary tuberculosis in the United States.
    Kass I
    Ann N Y Acad Sci; 1966 Jun; 132(2):892-900. PubMed ID: 4960375
    [No Abstract]   [Full Text] [Related]  

  • 40. The clearance of theophylline is increased during the initial period of tuberculosis treatment.
    Ahn HC; Lee YC
    Int J Tuberc Lung Dis; 2003 Jun; 7(6):587-91. PubMed ID: 12797703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.